Growing a business, from the lab
MIT researcher Shuguang Zhang’s nanofiber-scaffold technology became the foundation for a biotech company.
Creating a permanent bacteria barrier
Startup Semprus Biosciences develops a permanent solution for keeping bacteria off implanted medical devices.
Evaluating a new way to open clogged arteries
Computational model offers insight into mechanisms of drug-coated balloons.
Cells as living calculators
Using analog computation circuits, MIT engineers design cells that can compute logarithms, divide and take square roots.
The half-billion-dollar idea
While at MIT, alumnus Todd Zion developed an insulin product that ultimately drew the attention of a pharmaceutical giant.
Students have engineering on the brain
MIT class offers student teams a chance to create business ventures based on neurotechnology research.
From biotech to high-tech
Newer Kendall Square firms attribute their success to innovative ideas — and to location, location, location.
James Utterback honored as exemplar of excellence
Professor was honored by KU Leuven at its bi-annual Leuven International Forum.
Professor Roger Kamm visualizes sneaky tumor cells with 3-D assay
Kamm is studying the mechanics of metastasis, the process of cancer-cell migration from one location in the body to another and the cause of more than 90 percent of cancer deaths.
Precisely engineering 3-D brain tissues
New design technique could enable personalized medicine, studies of brain wiring.
A new way to create rare sugars
MIT team discovers an inorganic catalyst that could pave the way to a more robust synthesis of valuable rare sugars.
How better financing could help create new cancer drugs
MIT finance researchers say a diversified ‘megafund’ of securities could help the industry deliver new products to consumers.
Koch Institute, Dana-Farber/Harvard Cancer Center announce launch of 'Bridge Project' to attack most-lethal forms of cancer
Institutions, research teams, non-profit organizations join forces in novel approaches targeting pancreatic cancer, glioblastoma.
Moving past trial and error
Richard Braatz applies math to design new materials and processes for drug manufacturing.